TrialTrials2021

Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation.

Alberto Benazzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.